[144] Alignment Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) — Form 144 filing

An insider intends to sell up to 25,000 common shares (≈0.013% of the 198,031,417 shares outstanding) through broker Justin Tabit on or about 31 Jul 2025. The shares, valued at an estimated $398,750, were originally received on 6 Oct 2014 as equity awards from Joseph Konowiecki. No related sales have been made in the past three months. The filer confirms possession of no undisclosed material adverse information and notes potential reliance on a Rule 10b5-1 trading plan.

Insights

Securities Analyst

TL;DR: Minor insider sale (0.013% float); immaterial to valuation, but signals routine liquidity event.

The proposed disposition of 25,000 ALHC shares equates to roughly $0.4 million and a negligible fraction of shares outstanding. Such activity is common for option/award recipients and does not, in isolation, imply a bearish outlook. Absence of additional sales in the prior quarter and the standard Rule 144 representation reduce governance concerns. Investors should view the event as non-impactful unless it foreshadows a larger selling program.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Justin Tabit 9560 Wilshire blvd 3rd fl beverly hills CA 90212	25000	398750.00	198031417	07/31/2025	nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	10/06/2014	equity awards	Joseph Konowiecki			248000	10/06/2014	award

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Alignment Healthcare (ALHC) shares are being sold under this Form 144?

25,000 common shares are slated for sale.

What is the estimated market value of the proposed ALHC share sale?

The filing lists an aggregate market value of $398,750.

When is the anticipated sale date for the ALHC shares?

The filer targets 31 July 2025 for the transaction.

What percentage of Alignment Healthcare's outstanding shares does this sale represent?

Approximately 0.013% of the 198,031,417 shares outstanding.

Were any ALHC shares sold by this insider in the past three months?

No. The table reports "Nothing to Report" for prior three-month sales.